BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Shen L, Hong H, Li J, Wang H, Li X. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis. Eur J Pharmacol 2019;852:142-50. [PMID: 30876973 DOI: 10.1016/j.ejphar.2019.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaushal GP, Chandrashekar K, Juncos LA, Shah SV. Autophagy Function and Regulation in Kidney Disease. Biomolecules 2020;10:E100. [PMID: 31936109 DOI: 10.3390/biom10010100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
2 Wang Y, He W. Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney Disease. Front Pharmacol 2021;12:630617. [PMID: 33859563 DOI: 10.3389/fphar.2021.630617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Park K, Lee M. Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases. Front Cell Dev Biol 2022;10:811701. [DOI: 10.3389/fcell.2022.811701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xu F, Na L, Li Y, Chen L. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 2020;10:54. [PMID: 32266056 DOI: 10.1186/s13578-020-00416-0] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 52.0] [Reference Citation Analysis]
5 Sembach FE, Østergaard MV, Vrang N, Feldt-rasmussen B, Fosgerau K, Jelsing J, Fink LN. Rodent models of diabetic kidney disease: human translatability and preclinical validity. Drug Discovery Today 2021;26:200-17. [DOI: 10.1016/j.drudis.2020.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol 2020;16:269-88. [PMID: 32060481 DOI: 10.1038/s41581-019-0248-y] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 37.0] [Reference Citation Analysis]
7 Loganathan TS, Sulaiman SA, Abdul Murad NA, Shah SA, Abdul Gafor AH, Jamal R, Abdullah N. Interactions Among Non-Coding RNAs in Diabetic Nephropathy. Front Pharmacol 2020;11:191. [PMID: 32194418 DOI: 10.3389/fphar.2020.00191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
8 Li X, Wan T, Li Y. Role of FoxO1 in regulating autophagy in type 2 diabetes mellitus (Review). Exp Ther Med 2021;22:707. [PMID: 34007316 DOI: 10.3892/etm.2021.10139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lv J, Wu Y, Mai Y, Bu S. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy. J Diabetes Res 2020;2020:3960857. [PMID: 32656264 DOI: 10.1155/2020/3960857] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
10 Zhang M, Dong W, Li Z, Xiao Z, Xie Z, Ye Z, Liu S, Li R, Chen Y, Zhang L, Wang M, Liang H, Baihetiyaer R, Apaer R, Dong Z, Liang X. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury. Am J Physiol Renal Physiol 2021;320:F262-72. [PMID: 33356954 DOI: 10.1152/ajprenal.00289.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Liu S, Yuan Y, Xue Y, Xing C, Zhang B. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction. Front Cell Dev Biol 2022;10:832887. [DOI: 10.3389/fcell.2022.832887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fan X, Li Z, Wang X, Wang J, Hao Z. Silencing of KPNA2 inhibits high glucose-induced podocyte injury via inactivation of mTORC1/p70S6K signaling pathway. Biochem Biophys Res Commun 2020;521:1017-23. [PMID: 31727365 DOI: 10.1016/j.bbrc.2019.10.200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Liu S, Wu W, Liao J, Tang F, Gao G, Peng J, Fu X, Zhan Y, Chen Z, Xu W, Zhao S. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy. Front Endocrinol 2022;13:895010. [DOI: 10.3389/fendo.2022.895010] [Reference Citation Analysis]